Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy
Authors:
Open Access
- 1 January 2008
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 47 (1) , 56-62
Abstract
Background. An inverse association either between depression or impaired functional status and quality of life (QoL) has been reported for cancer patients, but the independent effect of depression or depressive symptoms and of functional impairment on QoL is unclear. Patients and methods. We investigated the prevalence of depression or depressive symptoms with the Beck Depression Inventory (BDI), the functional impairment with the ECOG-Performance-Status (ECOG-PS) and the QoL with the EORTC-QLQ-C30 questionnaire in a sample of 175 hospitalised cancer patients prior to the start of chemotherapy. Results. Sixteen of 175 patients (9.1%) screened positive for major depression, 29 (16.6%) had mild to moderate depressive symptoms. In 11 of 15 scales of the EORTC-QLQ-C30 questionnaire depression or depressive symptoms were significantly associated with worse QoL in univariate analysis and in 12 of 15 scales poor ECOG-PS was significantly associated with worse QoL. In multivariate analysis including ECOG-PS and BDI, the effect of depression and/or depressive symptoms on QoL was persistent in seven scales: global QoL, physical- and role functioning, fatigue, nausea & vomiting, pain, and constipation, that of ECOG-PS in five scales: global QoL, emotional functioning, nausea & vomiting, pain, and appetite loss. Conclusions. Signs of major depression or depressive symptoms and impaired functional status contribute independently to poorer QoL in cancer patients prior to chemotherapy.Keywords
This publication has 26 references indexed in Scilit:
- Predictors of quality of life in newly diagnosed melanoma and breast cancer patientsAnnals of Oncology, 2005
- Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptomsClinical Rheumatology, 2004
- Information needs and decision-making processes in older cancer patientsCritical Reviews in Oncology/Hematology, 2004
- Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancerPalliative Medicine, 2003
- Depressive symptoms and quality of life in home-care-assisted cancer patientsJournal of Pain and Symptom Management, 1996
- Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institutionEuropean Journal of Cancer, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Depression as measured by the DSM-III and the Beck Depression Inventory in an unselected adult population.Journal of Consulting and Clinical Psychology, 1984
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948